• 铜梁区旧县街道:全面提升执行力 推动工作落地见效 2019-07-14
  • 海南省纪委通报四起违反中央八项规定精神典型案例 2019-06-20
  • 紫光阁中共中央国家机关工作委员会 2019-06-20
  • 渭南警方历时8个月破获特大毒品案 抓获11名吸贩毒人员 2019-06-19
  • 一带一路中小企业国际合作高峰论坛花絮 2019-06-19
  • 热评丨中国,向大洋更深处挺进 2019-06-11
  • 【世界杯·望俄打卦】突尼斯VS英格兰,“欧洲的中国队”英格兰是否突围 2019-06-11
  • 戴利民的专栏作者中国国家地理网 2019-06-08
  • 五年来,习近平这样多次阐述中国梦 2019-06-07
  • 黄渤挑战苏绣“一出好戏” 2019-06-07
  • 留影记忆 看见非遗 2019-06-06
  • 上周济南8个项目推出新房源 1个纯新项目上市 ——凤凰网房产济南 2019-06-05
  • 获奖!亿达中国荣获中国房地产上市公司创新能力5强,综合实力50强 ——凤凰网房产北京 2019-06-05
  • 全球首例!这一整座城市,被列入“世界文化遗产” 2019-06-04
  • 中国工程院院士倪光南谈“发展核心技术 建设网络强国” 2019-06-03
  • 铜梁区旧县街道:全面提升执行力 推动工作落地见效 2019-07-14
  • 海南省纪委通报四起违反中央八项规定精神典型案例 2019-06-20
  • 紫光阁中共中央国家机关工作委员会 2019-06-20
  • 渭南警方历时8个月破获特大毒品案 抓获11名吸贩毒人员 2019-06-19
  • 一带一路中小企业国际合作高峰论坛花絮 2019-06-19
  • 热评丨中国,向大洋更深处挺进 2019-06-11
  • 【世界杯·望俄打卦】突尼斯VS英格兰,“欧洲的中国队”英格兰是否突围 2019-06-11
  • 戴利民的专栏作者中国国家地理网 2019-06-08
  • 五年来,习近平这样多次阐述中国梦 2019-06-07
  • 黄渤挑战苏绣“一出好戏” 2019-06-07
  • 留影记忆 看见非遗 2019-06-06
  • 上周济南8个项目推出新房源 1个纯新项目上市 ——凤凰网房产济南 2019-06-05
  • 获奖!亿达中国荣获中国房地产上市公司创新能力5强,综合实力50强 ——凤凰网房产北京 2019-06-05
  • 全球首例!这一整座城市,被列入“世界文化遗产” 2019-06-04
  • 中国工程院院士倪光南谈“发展核心技术 建设网络强国” 2019-06-03
  • 宝石探秘财富加倍游戏 博彩娱乐城网站大全 时时彩计划稳赢版 鬼屋电子 五子棋游戏在线玩 内蒙古十一选五走势图任五 全北现代vs广州恒大下半场 斯特拉斯堡到巴黎自驾 重庆时时彩预测 热血传奇手游
    Montelukast API and its key intermediates USP
    Rivaroxaban API and its key intermediates USP
    Ticagrelaor API and its key intermediates USP
    Ezetimibe API and its key intermediates USP
    Capecitabine API and its key intermediates USP
    Sitagliptin API and its key intermediates USP
    More>>      
    Add: BIdg 6,No.1 Huayun Road,
    Sangtiandao Science Innovation Park
    Tel: +86-512-62956319
    Sales hotline: +86-512-62959601
                              +86-15995748448
    Url: 体彩22选5分析

    Arromax Pharmaceutical Technology (Suzhou) Co., Ltd. is a high-tech enterprise founded by returning students, located at Sangtian Island Innovation Park in the high-tech industrial zone-Suzhou Industrial Park (SIP), Suzhou.

    The company focuses on international first-class drug discovery research and innovative technology for product development, involving anti-tumor, cardiovascular, central nervous system, anti-infection and other fields of therapeutic drugs and generic drug synthesis process. The company provides innovative discovery services of new drugs and new clinical candidate identification for domestic and foreign pharmaceutical companies. It provides process development and synthesis of high-quality APIs and their intermediates.

    Arromax Pharmaceutical Technology (Suzhou) Co., Ltd. has experienced R & D team who has been recognized by the Scientific communities...

    Synthetic method of Montelukast Soudium API
    Synthetic method of Capecitabine API
    Synthetic method of Ezetimibe API
    Synthetic method of RivaroxabanAPI
    Synthetic method of Ticagrelor HCl API
    Synthetic method of Sitagliptin phosphate monohydrate API

    We have nearly 2000 square meters of research area, including small scale Synthesis laboratory, Kilo Labs, quality analysis laboratory and preparation prescription research laboratory.
    Our major research equipments include Waters 2695,  Angilent 1100  and other high-performance liquid chromatography (HPLC) and high-efficiency gas chromatograph, stability test box, 100L glass reaction vessels, large rotary evaporators, centrifuge, moisture analyzer, melting point apparatus, Spinner, ultraviolet, infrared,  polarimeter and so on.
    ◇1.1 New anticancer Drug AMX3009
    ◇1.1 New anticancer Drug AMX5035
    ◇1.1 New anticancer Drug AMX6001

     
    Home | About Us | www.en-cphi.cn | R & D | Technology transfer | Products | Contact | 中文版???【Admin login】
    Copyright(C)2013, Arromax Pharmatech Co., Ltd. All Rights Reserved.Supported by ChemNet ChinaChemNet Toocle Copyright Notice